MSLENasdaqPharmaceutical PreparationsFiscal year ends December 31
Satellos Bioscience Inc.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 27, 2026
$6.44−0.02 (-0.31%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Jan 30, 2026 | 1-for-12 reverse | Earlier per-share figures multiplied by 12 |
| Aug 18, 2021 | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |